Thomas Soloway

Thomas Soloway

Director/Board Member at THIRD HARMONIC BIO, INC.
59 year
Health Technology
Consumer Services
Finance

Profile

Thomas M.
Soloway
was the founder of Transcept Pharma, Inc. (2002) and served as SVP, Chief Operating & Financial Officer from 2012 to 2013.
Current jobs include Chief Executive Officer at T-Knife GmbH since 2021, President & Chief Executive Officer at T-Knife Therapeutics, Inc., and Independent Director at Third Harmonic Bio, Inc. since 2022.
Former jobs include Director at Novacea, Inc. in 2009, Independent Director at Satsuma Pharmaceuticals, Inc. from 2020 to 2023, Principal at Montreux Equity Partners, Inc. from 1993 to 2002, Senior Vice President-Media at Ascendis Pharma A from 2015 to 2019, Chief Financial Officer, Treasurer & Senior VP at Astellas Gene Therapies, Inc. in 2020, and Chief Operating Officer at Paratek Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Southern California and an MBA from Georgetown University.

Thomas Soloway active positions

CompaniesPositionStart
THIRD HARMONIC BIO, INC. Director/Board Member 01/07/2022
Chief Executive Officer 19/01/2021
Chief Executive Officer -

Former positions of Thomas Soloway

CompaniesPositionEnd
SATSUMA PHARMACEUTICALS, INC. Director/Board Member 08/06/2023
AUDENTES THERAPEUTICS, INC. Director of Finance/CFO 01/09/2020
ASCENDIS PHARMA A/S Director of Finance/CFO 01/09/2015
Founder 01/12/2013
Director/Board Member 06/02/2009
See the detail of Thomas Soloway's experience

Training of Thomas Soloway

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Thomas Soloway
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!